Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients

Faith L. Anderson(Dartmouth College), Matthew C. Havrda(Dartmouth–Hitchcock Medical Center)

npj Parkinson s Disease

January 4, 2021

10.1038/s41531-020-00147-6

Cited by 81

Related Papers

NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

|npj Parkinson s Disease|2018|186

NLRP3 inflammasome in neurodegenerative disease

|Translational research|2022|125

Editor’s Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice

|Toxicological Sciences|2017|57

Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson’s Disease

|Toxicological Sciences|2018|47